Dual contraceptives and associated predictors in HIV positive women: a case-control study
- PMID: 35906704
- PMCID: PMC9336104
- DOI: 10.1186/s12978-022-01475-x
Dual contraceptives and associated predictors in HIV positive women: a case-control study
Abstract
Background: People living with the human immune deficiency virus (PLHIV) are an important group to address HIV prevention. Mostly, 90% of the HIV cases in children are usually through mother-to-child transmission. Dual contraception (barrier condoms i.e., male, and female condoms) are one of the most effective ways to avoid HIV transmission. Thus, the present study was carried out to establish the predictors associated with the use of dual contraceptives in sexually active HIV positive women in Hossana, Southern Ethiopia.
Methods: An institution based unmatched case-control study among randomly selected 312 sexually active HIV positive women was conducted from February 2021 to May 2021. The data were collected through structured questionnaire and anti-retroviral treatment (ART) cards considering the case-to-control ratio of 1:3. The information was coded, entered into Epi-Info7.0 and exported to SPSS 20.0 for further analysis. A P-value < 0.25 in bi-variate analysis was further processed for multi-variate analysis and P-value < 0.05 was considered statistically significant.
Results: A response rate of 97.2% was recorded. A significant difference was observed towards the use of dual contraceptives in sexually active HIV positive women living in urban vs rural areas (AOR = 0.28; 95% CI = 0.09-0.84), having sexual intercourse with a regular partner (AOR = 3.77; 95% CI = 1.48-9.55) and taking first initiation to use (AOR = 0.05; 95% CI = 0.02-0.11).
Conclusion: The determinants associated with lower use of dual contraceptives were residing in rural areas, sexual intercourse with a regular partner and low initiation rate at first time for use of dual contraceptives. Therefore, we strongly recommend that open discussion about sexually transmitted infections like HIV and their prevention, providing adequate facilities in rural areas can help to prevent HIV transmission and reduce the disease burden. The health professionals are encouraged to organize awareness campaigns in rural areas for use of dual contraceptives among PLHIV.
Keywords: AIDS; Antiretroviral therapy; Dual contraceptives; HIV; Sexually active women.
Plain language summary
HIV/AIDS has become a serious global threat to human beings. People living with HIV are an important group that needs attention. About 90% of the children get HIV infection through their mothers that involved mother-to-child transmission of HIV. Therefore, World Health Organization has focused on the use of condoms to prevent the transmission of sexually transmitted diseases (STDs) and to avoid unwanted pregnancies. Out of these contraceptives, the use of dual contraceptives has been considered the best to prevent the transmission of STDs/HIV. Therefore, the present study tried to identify the use of dual contraceptives (barrier condoms i.e., male, and female condoms) and factors associated with its use in sexually active HIV women in Hossana, SNNPR, Ethiopia. We conducted a case–control study and recruited 312 sexually active HIV positive women that were on antiretroviral therapy and visiting the ART clinics for their follow-ups. The present investigation revealed that women living in rural areas were not aware about the use of dual contraceptives when compared to urban areas. Also, it was observed that women, those involved in sexual activities with multiple partners and had an open discussion with their partners about using dual contraceptives at first were more when compared to others. Although, the use of dual contraceptives among HIV positive women living in Hossana was low. Hence, this needs more focused awareness programs in rural areas and people having sexual intercourse with regular partners.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they do not have any competing interests.
Figures
Similar articles
-
Dual contraception method utilization and associated factors among sexually active women on antiretroviral therapy in Gondar City, northwest, Ethiopia: a cross sectional study.BMC Womens Health. 2020 Feb 12;20(1):26. doi: 10.1186/s12905-020-0890-3. BMC Womens Health. 2020. PMID: 32050961 Free PMC article.
-
Utilization of dual contraception method among reproductive age women on antiretroviral therapy in selected public hospitals of Northern Ethiopia.Reprod Health. 2017 Oct 5;14(1):125. doi: 10.1186/s12978-017-0390-6. Reprod Health. 2017. PMID: 28982364 Free PMC article.
-
Patterns of condom use and sexual behavior among never-married women.Sex Transm Dis. 1993 Jul-Aug;20(4):201-8. doi: 10.1097/00007435-199307000-00005. Sex Transm Dis. 1993. PMID: 8211537
-
[Current status of the female condom in Africa].Sante. 1997 Nov-Dec;7(6):405-15. Sante. 1997. PMID: 9503499 Review. French.
-
Contraceptives of the future in the light of HIV infection.Aust N Z J Obstet Gynaecol. 1994 Jun;34(3):330-2. doi: 10.1111/j.1479-828x.1994.tb01083.x. Aust N Z J Obstet Gynaecol. 1994. PMID: 7848210 Review.
Cited by
-
Use of female-controlled dual protection methods among adolescent girls and young women living with HIV in Northern Uganda: A convergent mixed-methods study.PLoS One. 2025 Jul 7;20(7):e0326768. doi: 10.1371/journal.pone.0326768. eCollection 2025. PLoS One. 2025. PMID: 40623039 Free PMC article.
-
Dual contraceptive use among women living with HIV on anti-retroviral therapy in Boset district, Ethiopia.Front Glob Womens Health. 2025 Apr 1;6:1510299. doi: 10.3389/fgwh.2025.1510299. eCollection 2025. Front Glob Womens Health. 2025. PMID: 40236950 Free PMC article.
References
-
- https://www.unaids.org/en/regionscountries/countries/ethiopia 2020. Accessed Aug 2021.
-
- GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392: 1789–1858 - PMC - PubMed
-
- Harikrishnan S, Jeemon P, Mini GK, et al. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–1788. doi: 10.1016/S0140-6736(18)32203-7. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical